Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orofino Pharmaceuticals Group (OPG) is a leading Italian Contract Development and Manufacturing Organization (CDMO) that provides comprehensive services to the global pharmaceutical industry. The company specializes in the development and large-scale production of a diverse range of pharmaceutical forms, including sterile injectables, oral solids, and liquid formulations. Operating out of high-capacity facilities in Italy, OPG offers end-to-end solutions encompassing formulation development, analytical testing, and specialized packaging. The group is recognized for its adherence to stringent GMP standards and its ability to support both small-scale clinical batches and high-volume commercial manufacturing for international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orofino Pharmaceuticals Group.